| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
AllWays Health Partners
| Facility | $1,269.68 | $1,269.68 | $4,254.29 | |
Mass General Brigham
| Facility | $1,269.68 | $1,269.68 | $4,254.29 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab, includes infusion or injection, and post administration monitoring in the home or residence. This includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
AllWays Health Partners
| Facility | $1,269.68 | $1,269.68 | $4,254.29 | |
Mass General Brigham
| Facility | $1,269.68 | $1,269.68 | $4,254.29 |